166 related articles for article (PubMed ID: 33254033)
1. Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?
Langabeer SE; Bhreathnach Ú; Cahill MR; Elhassadi E; Ní Loingsigh S; Conneally E; Enright H
Blood Cells Mol Dis; 2021 Mar; 87():102521. PubMed ID: 33254033
[No Abstract] [Full Text] [Related]
2. The thin line between CML and CMML.
Parilla M; Venkataraman G
Blood; 2017 Apr; 129(17):2456. PubMed ID: 28450577
[No Abstract] [Full Text] [Related]
3. Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia.
Podvin B; Guermouche H; Roynard P; Goursaud L; Berthon C; Ouafi M; Fourner E; Duployez N; Nibourel O; Roche-Lestienne C
Ann Hematol; 2022 Sep; 101(9):2093-2095. PubMed ID: 35562492
[No Abstract] [Full Text] [Related]
4. Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.
Lee J; Kim DS; Lee HS; Choi SI; Cho YG
Ann Lab Med; 2017 Jan; 37(1):74-76. PubMed ID: 27834071
[No Abstract] [Full Text] [Related]
5. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib for chronic myelomonocytic leukemia with ZMIZ1-ABL1 fusion gene: a case report.
Liu H; Bai H; Zhang S; Zhao X; Mao D; Xi R
Int J Hematol; 2023 Jun; 117(6):929-932. PubMed ID: 36694063
[TBL] [Abstract][Full Text] [Related]
7. Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia.
Satoh Y; Masuda A; Jona M; Nannya Y; Yokota H; Kurokawa M; Yatomi Y
Eur J Haematol; 2014; 92(5):456-7. PubMed ID: 24373003
[No Abstract] [Full Text] [Related]
8. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
[TBL] [Abstract][Full Text] [Related]
10. Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients.
Arun AK; Senthamizhselvi A; Mani S; Vinodhini K; Janet NB; Lakshmi KM; Abraham A; George B; Srivastava A; Srivastava VM; Mathews V; Balasubramanian P
Int J Lab Hematol; 2017 Jun; 39(3):235-242. PubMed ID: 28035733
[TBL] [Abstract][Full Text] [Related]
11. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.
Aye le L; Loghavi S; Young KH; Siddiqi I; Yin CC; Routbort MJ; Liang M; Eilerman K; Medeiros LJ; Brynes RK; Bueso-Ramos C
Ann Diagn Pathol; 2016 Apr; 21():53-8. PubMed ID: 27040932
[TBL] [Abstract][Full Text] [Related]
12. Philadelphia chromosome-positive chronic myeloid leukemia expressing p190(BCR-ABL).
Ohsaka A; Shiina S; Kobayashi M; Kudo H; Kawaguchi R
Intern Med; 2002 Dec; 41(12):1183-7. PubMed ID: 12521212
[TBL] [Abstract][Full Text] [Related]
13. BCR-ABL1 p210 screening for chronic myeloid leukemia in patients with peripheral blood cytoses.
Fenu E; O'Neill SS; Insuasti-Beltran G
Int J Lab Hematol; 2021 Dec; 43(6):1458-1464. PubMed ID: 34185393
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts.
Xue M; Wang Q; Huo L; Wen L; Yang X; Wu Q; Pan J; Cen J; Ruan C; Wu D; Chen S
Leuk Lymphoma; 2019 Dec; 60(12):3051-3057. PubMed ID: 31258010
[TBL] [Abstract][Full Text] [Related]
15. Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.
Ha J; Cheong JW; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 May; 36(3):287-9. PubMed ID: 26915625
[No Abstract] [Full Text] [Related]
16. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib.
Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Larráyoz MJ; Lahortiga I; Andreu EJ; Márquez J; Beltrán de Heredia JM; Odero MD; Prósper F; Calasanz MJ
Cancer Genet Cytogenet; 2005 Jul; 160(1):22-6. PubMed ID: 15949566
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Xpert
Dominy KM; Simon IM; Sorouri-Khorashad J
Int J Lab Hematol; 2021 Feb; 43(1):e31-e34. PubMed ID: 32990400
[No Abstract] [Full Text] [Related]
18. BCR-ABL1 mutation screening in chronic myeloid leukaemia: is next now?
Soverini S; Martelli M; Bavaro L
Lancet Haematol; 2019 May; 6(5):e236-e237. PubMed ID: 31036315
[No Abstract] [Full Text] [Related]
19. A diagnostic dilemma: chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia. A case report and review of the literature.
Misialek MJ; Pechet L
Acta Haematol; 1997; 98(4):221-7. PubMed ID: 9401502
[TBL] [Abstract][Full Text] [Related]
20. BCR-ABL Testing by Polymerase Chain Reaction in Patients With Neutrophilia: The William Beaumont Hospital Experience and the Case for Rational Laboratory Test Requests.
Ogunleye F; Ibrahim M; Allen E; Brennan N; Huang J; Yu Z; Huben M; Jaiyesimi I
J Oncol Pract; 2016 Dec; 12(12):e1001-e1005. PubMed ID: 27624943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
